Massachusetts Eye and Ear Infirmary

Summary

Massachusetts Eye and Ear Infirmary is a medical facility located in Boston, Massachusetts. This center is recognized for care of Retinitis Pigmentosa, Macular Degeneration, Glaucoma, Hearing Loss, None and other specialties. Massachusetts Eye and Ear Infirmary is involved with conducting 136 clinical trials across 262 conditions. There are 16 research doctors associated with this hospital, such as Kristina Simonyan, MD, PhD, D. Bradley Welling, MD, PhD, Ula Jurkunas, MD, and Michael Cohen, MD.

Top PIs

Clinical Trials running at Massachusetts Eye and Ear Infirmary

Stargardt Disease

Glaucoma

Hearing Loss

Dystonia

Retinitis Pigmentosa

Age-Related Macular Degeneration

Macular Degeneration

Retinal Disease

Dysphonia

Spasmodic Dysphonia

Prescreening

for Stargardt Disease

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.

Recruiting

1 award

N/A

3 criteria

ACDN-01

for Stargardt Disease

This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical trial in which ACDN-01 will be evaluated for safety, tolerability, and preliminary efficacy following a single subretinal injection of ACDN-01.

Recruiting

1 award

Phase 1 & 2

3 criteria

SB-007

for Stargardt Disease

This Phase 1/2 study will evaluate the safety, tolerability, and preliminary efficacy of subretinal SB-007 administration to determine dose selection in subjects with Stargardt's Type 1 (STGD1). This is a multicenter study which will enroll approximately 57 subjects, followed up over a 96 week period post treatment after a single administration of SB-007.

Recruiting

1 award

Phase 1 & 2

3 criteria